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Recurrent chromosomal translocations can drive oncogenesis, but how they form has remained
elusive. Now, Chiarle et al. (2011) and Klein et al. (2011) characterize the genome-wide spectrum
of translocations that form from a single double-stranded break, revealing that specific loci have
an intrinsic predisposition for frequent chromosomal rearrangements.In the face of damage from everyday
metabolic processes or external ionizing
radiation, a cell must maintain chromo-
somal integrity. The most dangerous
event that it can face is a DNA double-
strand break (DSB), which can lead to
chromosomal translocations (Mills et al.,
2003). Chromosomal translocations are
a common feature of many cancers, with
specific, recurrent translocations occur-
ring in nearly 40% of all human tumors
(Shaffer and Pandolfi, 2006).
Recurrent translocations can promote
tumorigenesis by creating novel gene
products or by altering the regulation of
genes involved in cell proliferation and
differentiation. For example, the Bcr/Abl
translocation, observed in 90% of chronic
myelogenous leukemia cases, creates
a novel oncogene that is sufficient to
transform cells in vitro. Why do recurrent
translocations occur so frequently?
They could result from random and rare
events that are subsequently selected
due to their proliferative potential. Alter-
natively, molecular processes could
predispose specific loci to engage
frequently in translocations. In this issue,
Klein et al. and Chiarle et al. present
powerful new methods to address such
questions by capturing the genome-wide
landscape of translocations (a trans-
locatome), which result from a single
defined DSB in primary cells in the
absence of confounding effects of growth
selection (Chiarle et al., 2011; Klein et al.,
2011).
The two methods induce a DSB at a
defined position in the genome. After
allowing the cells to repair this DSB for20 Cell 147, September 30, 2011 ª2011 Elsea relatively short time, translocation junc-
tions between the induced DSB and
endogenous DSBs are identified by
PCR amplification and deep sequencing.
Both studies find that most cells repair
the induced DSB by rejoining the ends
without causing major genomic rear-
rangements. However, a significant frac-
tion of cells join the induced DSB ends
with endogenous DSBs elsewhere in the
genome, creating intra- and interchromo-
somal rearrangements.
Though these technologies can be
widely applied to any cellular system,
both groups use them to examine ge-
nomic rearrangements in murine B cells.
These immune cells can give rise to
lymphomas as a result of a recurrent
interchromosomal translocation between
the c-myc gene and the IgH locus
(Ku¨ppers and Dalla-Favera, 2001). In
these two studies, the authors condition-
ally introduce a DSB at either the IgH or
the c-myc locus in B cells activated
for class switch recombination (CSR),
a process that generates a spectrum of
endogenous DSBs. They find that B cells
minimize the risk of deleterious transloca-
tions from all of these DSBs by repairing
almost half of the induced DSBs locally,
within 1 kb of the original break site.
Even within 100 kb of the break site,
some junctions can be attributed to the
local repair process of resection and re-
sealing. Outside of local repair, however,
the authors observe a multitude of trans-
location partners of c-myc and IgH that
could generate almost every chromo-
somal aberration imaginable, including
di-centric and a-centric chromosomes.vier Inc.This diversity shows the power of
capturing an early, unselected transloca-
tome, as many of these rearrangements
would have been lost if cells were required
to undergo cell division. Importantly,
these studies reveal that the frequency
of translocations derived from a single
DSB is 0.4%–1%. In a living organism,
where millions of B cells per day experi-
ence endogenous DSBs during CSR, the
observed translocation rate predicts that
nearly 103 cells per day could form inad-
vertent translocations.
With distinct yet similar experimental
protocols, these two studies paint a
picture of some of the underlying mecha-
nisms that predispose certain regions to
translocations in B cells (Figure 1). For
instance, both groups find that transloca-
tions occur more frequently on the chro-
mosome carrying the induced break,
even up to 50 Mb away. Such a phenom-
enon cannot be explained by local repair
activity but, rather, suggests that translo-
cations between pairs of DSBs occurring
on the same chromosome are strongly
preferred over interchromosomal events.
Given that loci on the same chromosome
tend to be located closer to each other in
the nucleus than loci on different chromo-
somes, the spatial organization of the
genome may directly impact the forma-
tion of translocations.
Despite the enrichment for intrachro-
mosomal translocations, the authors
find that interchromosomal transloca-
tions occur frequently, comprising 60%
of the nonlocal repair events. Some
chromosomal regions translocate so fre-
quently that they are classified as ‘‘hot
Figure 1. Factors Predisposing Loci to Double-Strand Breaks and Translocations
Genome-wide translocation mapping identifies translocations that form when a DNA double-strand break
(DSB) is artificially introduced in a defined location by the I-SceI meganuclease (center). The majority of
induced DSBs are repaired locally, but many form translocation junctions with endogenous DSBs. These
endogenous DSBs, often mediated by AID activity, occur at transcription start sites (left), class switch
recombination sites (top), and elsewhere throughout the genome (right).spots.’’ Among these, the c-myc/IgH
translocation is among the most frequent,
regardless of whether the original break
was introduced at c-myc or IgH. What
mechanisms might explain the recurrent
formation of certain translocations? Both
studies find that many hot spots depend
on activation-induced cytidine deaminase
(AID). AID initiates CSR and somatic hy-
permutation by inducing DNA damage at
immunoglobulin (Ig) loci (Yamane et al.,
2011). Importantly, Klein et al. (2011) and
Chiarle et al. (2011) show that this enzyme
not only acts at canonical target loci, but
also at additional sites throughout the
genome, initiating DSBs that can lead to
translocations. Thus, B cells pay a price
for their programmed ability to rearrangeIg loci by acquiring DNA damage else-
where in the genome.
Even in the absence of AID-dependent
DSBs, there are numerous nonrandom
translocations throughout the genome.
Both studies find that translocations are
much more likely to happen near tran-
scription start sites (TSSs) of actively
transcribed genes. Though this effect is
pronounced when AID is present (AID
induces DSBs at exposed cytosines re-
vealed by stalled RNA polymerases; Pavri
et al., 2010), transcription alone creates
a risk of DSBs.
Together, these studies show that
transcription, the generation of breaks
by AID, and physical linkage along the
DNA all affect translocation frequencyCell 147, S(Figure 1). Importantly, the presence of
translocation hot spots in the absence of
selection suggests that recurrent translo-
cations observed in disease may have
mechanistic causes rather than solely
being observed due to selection. Recur-
rent translocations in cancer may result
from intrinsic mechanisms and thus may
or may not be drivers of disease. The
broad distribution of translocations, along
with the likelihood that these rearrange-
ments occur near gene promoters,
explains the high risk of acquiring novel
gene products and translocation-driven
cancers.
These studies highlight the molecular
processes that lead to formation of
DSBs at particular genomic sites.
However, for a translocation to occur,
two DSBs must also come into close
proximity. How and when this contact
occurs has long been debated in terms
of two contrasting models. The ‘‘contact
first’’ model proposes that only regions
of chromosomes already in contact prior
to DSB formation can form translocations,
whereas the ‘‘breakage first’’ model
hypothesizes that DSBs can move in the
nuclear space to contact translocation
partners (Meaburn et al., 2007). The
results of the studies from Klein et al.
(2011) and Chiarle et al. 2011 suggest
that spatial genome organization may
affect translocation frequency, but neither
study resolves which of the two models
applies. The tendency of translocations
to occur on the same chromosome as
the engineered break site suggests that
close spatial proximity can contribute to
formation of specific translocations.
Indeed, other studies have reported that
IgH and c-myc are closely juxtaposed
even before a DSB occurs (Roix et al.,
2003), possibly facilitating translocation
formation when DSBs are introduced.
However, the extent to which loci move,
especially when CSR and somatic hyper-
mutation are activated, remains unre-
solved. We now have the ability to
comprehensively determine the initiating
translocatomes; combining such tech-
niques with other genome-wide assays
that probe chromatin state and spatial
conformation (Lieberman-Aiden et al.,
2009) will contribute to a better under-
standing of the mechanisms that lead to
recurrent formation of disease-causing
genomic rearrangements.eptember 30, 2011 ª2011 Elsevier Inc. 21
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In this issue ofCell, Gabut and colleagues (2011) identify a new splice variant of FOXP1 that directly
regulates the expression of pluripotency genes. It endows human embryonic stem cells with their
pluripotent nature and is required for the reprogramming of somatic cells to induced pluripotent
stem cells.The past few years have seen remarkable
progress inourunderstandingof themech-
anistic basis of pluripotency, including the
identification of key factors required for
maintaining the pluripotent state of human
embryonic stem cells (ESCs) (Chen et al.,
2008; Kim et al., 2008; Silva et al., 2009).
Moreover, one of the great breakthroughs
of this decade was the discovery that
a only few critical transcriptions factors,
such as the combination of Oct4, Sox2,
Klf4, and c-Myc, are sufficient to repro-
gram somatic cells into induced pluripo-
tent stem (iPS) cells (Takahashi et al.,
2007). These factors appear to activate
a transcriptional network that endowscells
with pluripotency (Samavarchi-Tehrani
et al., 2010), but gene expression can be
regulated by numerous processes other
than transcription, including chromatin
modifications, RNA stability, and pre-
RNA splicing. How these processes
contribute topluripotency has been largely
understudied in human ESCs. Now in this
issue of Cell, Gabut et al. (2011) break
this field wide open by identifying an alter-native splicing ‘‘switch’’ at the top of the
pluripotency transcriptional network.
Alternative splicing—the process by
which exons can be joined together in
different patterns such that a single gene
can give rise to multiple transcripts—is
known to regulatekeydevelopmental deci-
sions in a number of systems (Nilsen and
Graveley, 2010). Perhaps the best known
example is the sex-determination pathway
in Drosophila (Salz, 2011). This pathway
consists of five genes encoding pre-
mRNAs that are spliced in a sex-specific
manner (Figure 1A). The genes are orga-
nized in a hierarchy in which the splicing
of an upstream gene regulates that of
downstream genes. The genes at the
bottom of this hierarchy, dsx (doublesex)
and fru (fruitless), encode transcription
factors, and the male-specific and
female-specific protein variants of each
factor regulatedistinct setsof target genes.
Thus, these regulated splicing events act
in a switch-like manner to specify nearly
all aspects of sex determination and court-
ship behavior.To explore the role of alternative
splicing in human ESC pluripotency, Ga-
but et al. use microarrays that can detect
different splicing variants. These experi-
ments reveal numerous splicing events
that change as human ESCs differentiate
into neural precursor cells, including one
in the FOXP1 gene. This event involves
a previously unannotated exon that is
included in human ESCs but skipped in
differentiated cells (Figure 1B). Strikingly,
the exon’s sequence and its stem cell
specificity is conserved in mouse, sug-
gesting that it might play a significant
role in stem cell biology.
FOXP1 encodes a member of the fork-
head family of transcription factors, which
recognize particular DNA sequences
through a ‘‘forkhead domain.’’ FOXP1 is
an essential gene that is broadly ex-
pressed and required for the establish-
ment of specific cell types. Fusions of
FOXP1 with other genes or loss of FOXP1
function are associated with many dif-
ferent types of cancer (Wang et al., 2004;
Dasen et al., 2008). Intriguingly, the
